The purpose of this disclosure is to explain how we make money without charging you for our content.
Our mission is to help people at any stage of life make smart financial decisions through research, reporting, reviews, recommendations, and tools.
Earning your trust is essential to our success, and we believe transparency is critical to creating that trust. To that end, you should know that many or all of the companies featured here are partners who advertise with us.
Our content is free because our partners pay us a referral fee if you click on links or call any of the phone numbers on our site. If you choose to interact with the content on our site, we will likely receive compensation. If you don't, we will not be compensated. Ultimately the choice is yours.
Opinions are our own and our editors and staff writers are instructed to maintain editorial integrity, but compensation along with in-depth research will determine where, how, and in what order they appear on the page.
To find out more about our editorial process and how we make money, click here.
“If you think about the business model, needles, syringes are used once; they’re thrown away and more are bought,” says Robert McIver, managing director at Jensen Investment Management and a portfolio manager of the $5 billion Jensen Quality Growth fund . McIver says there are three main reasons Jensen likes the health care sector: advances in medical technology, an aging population in many countries, and growth in health care spending by emerging economies. In the U.S., McIver says Jensen was worried about the Affordable Healthcare Act of 2010, but the dust appears to have settled.